The Senores Pharmaceuticals IPO has begun on 20-December-2024. It will close on 24-December-2024. The Total IPO Size is 582.11 Crores. The company set its IPO price is 391 Rs Per Share.
Basically, there are three basic categories in Senores Pharmaceuticals IPO Subscription 1) Qualified Institutional Buyers 2) Non-Institutional Investors 3) Retails.
Senores Pharmaceuticals is incorporated in 2017.
Senores Pharmaceuticals is engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the Regulated Markets across various therapeutic areas and dosage forms, with a presence in Emerging Markets.
The business is primarily focussed on the Regulated Markets of US and Canada. They have a presence in the Emerging Markets across 43 countries. They also manufacture critical care injectables and APIs.
Client Includes :
Alkem Labs, Lannett Company Inc, Prasco LLC, Sun Pharma, Jubilant Pharmova, Cintex Services, Dr.Reddy’s, Amici, Mint Pharmaceuticals Inc, Solco Healthcare, Ambicare, Waymade PLC Etc
Objects Of The Issue :
1. Capital Expenditure Towards Setting Up Injectables Facility At Atlanta US Plant.
2.Repayment Of Debt.
3.Funding Inorganic Growth Initiatives.
4.Funding Working Capital.
Swapnil Jatinbhai Shah and Ashokkumar Vijaysinh Barot are the promoters of the company.
Senores Pharmaceuticals IPO Date, Details & Price Band
The Senores Pharmaceuticals IPO Price Band, IPO Dates, Market lot and other details mention in be below table.
| IPO Opening Dates | 20-December-2024 |
| IPO Closing Dates | 24-December-2024 |
| Price | 372-391 Rs |
| Fresh Issue | 500.00 Crores |
| Offer for Sale | 82.11 Crores |
| Total IPO size | 582.11 Crores |
| Face Value | 10 INR Per Share |
| Issue Type | Book Built Issue |
| QIB Allocation | 50% |
| HNI Allocation | 15% |
| Retail Allocation | 35% |
| Listing On | NSE, BSE |
Senores Pharmaceuticals IPO Market Lot
The Senores Pharmaceuticals IPO minimum market lot is 38 shares With 14,858 ₹ Amount per application.
| Lot | No of Shares | Amount | |
| Retail Minimum | 1 | 38 | 14,858 ₹ |
| Retail Maximum | 13 | 494 | 1,93,154 ₹ |
| S-HNI Minimum | 14 | 532 | 2,08,012 ₹ |
| S-HNI Maximum | 68 | 2,546 | 9,95,486 ₹ |
| B-HNI Minimum | 68 | 2,584 | 10,10,344 ₹ |
Restated Financial Record of the three year (Amt. in Crore)
| Total Assets | Total Revenue | Profit After Tax | |
| 30-Sep-24 | 678.08 | 183.35 | 23.94 |
| 31-Mar-24 | 621.88 | 217.34 | 32.71 |
| 31-Mar-23 | 131.05 | 39.02 | 8.43 |
Senores Pharmaceuticals IPO GMP & Grey Market Premium
Senores Pharmaceuticals IPO GMP Grey market premium has been started today. Check Latest Senores Pharmaceuticals PO GMP, Kostak Rates and Subject to Sauda Price here.
Senores Pharmaceuticals IPO Prospectus
Senores Pharmaceuticals IPO Prospectus Available on BSE and Sebi Website as well as on our Portal. Please click here to Download Senores Pharmaceuticals IPO Prospectus.
| DRHP | Download |
| RHP | Download |
Senores Pharmaceuticals IPO Allotment Date & Details
| Allotment Date | 26-December-2024 |
| Initiation of refunds | 27-December-2024 |
| Transfer of shares to Demat accounts | 27-December-2024 |
| Listing Date | 30-December-2024 |
| Check Allotment Status | Click here |
Registrar of Senores Pharmaceuticals
Link Intime India Private Limited
C 101, 1st Floor, 247 Park
Lal Bahadur Shastri Marg, Vikhroli (West)
Maharashtra, India 400083
Tel: +91 8108114949
E-mail: [email protected]
Website: www.linkintime.co.in
Investor grievance e-mail:
[email protected]
Contact person: Shanti Gopalkrishnan
SEBI Registration No.: INR000004058
Senores Pharmaceuticals Contact Details
Senores Pharmaceuticals Limited
1101 to 1103, 11th floor,
South Tower, ONE 42 oppositeJayantilal Park,
Ambali Bopal Road, Ahmedabad,-380054
Phone: +91-79-29999857
Email: [email protected]
Website: https://senorespharma.com/
Senores Pharmaceuticals IPO Lead Managers
Equirus Capital Private Limited
12th Floor, C Wing, Marathon Futurex,
N.M. Joshi Marg, Lower Parel,
Mumbai – 400013
Maharashtra, India
Tel.: +91 22 4332 0735
E-mail: [email protected]
Website: www.equirus.com
Investor grievance e-mail:
[email protected]
Contact person: Jenny Bagrecha
SEBI Registration Number:
INM000011286
Ambit Private Limited
Ambit House, 449 Senapati Bapat Marg
Lower Parel, Mumbai 400 013
Maharashtra, India
Tel.: + 91 22 6623 3030
E-mail : [email protected]
Website: www.ambit.co
Investor grievance e-mail:
[email protected]
Contact Person: Miraj Sampat
SEBI Registration Number: INM000010585
Nuvama Wealth Management Limited (formerly
known as Edelweiss Securities Limited)
801 – 804, Wing A, Building No 3
Inspire BKC, G Block, Bandra Kurla Complex,
Bandra East, Mumbai 400 051
Maharashtra, India
Tel.: +91 22 4009 4400
E-mail : [email protected]
Website: www.nuvama.com
Investor grievance e-mail: customerservice.mb@nuva
ma.com
Contact Person: Lokesh Shah
SEBI Registration Number: INM000013004